Marek Ostrowski

Protein Abundance of Clinically Relevant Multidrug Transporters along the Entire Length of the Human Intestine

Marek Droździk, Christian Gröer, Jette Penski et al. · Molecular Pharmaceutics · 2014 · 255 citations

Medicine, Biochemistry, Pharmacology +16

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Peter Palmer, J. Vinke, Thierry Philip et al. · Annals of Oncology · 1992 · 156 citations · Full text

Medicine, Immunology, Oncology +14

Protein Abundance of Clinically Relevant Drug‐Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens

Marek Droździk, Diana Busch, Janett Müller et al. · Clinical Pharmacology & Therapeutics · 2017 · 138 citations

Medicine, Biochemistry, Pharmacology +17

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?

R.T.D. Oliver, Polly Edmonds, J. Ong et al. · International Journal of Radiation Oncology*Biology*Physics · 1994 · 133 citations

Medicine, Oncology, Chemotherapy +9

Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial

J.-P Squifflet, Marek Ostrowski, Paolo Rigotti et al. · American Journal of Transplantation · 2009 · 127 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17